1832 Asset Management
AUPH icon

1832 Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

1832 Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-200
Closed -$1K – 623
2015
Q2 		$1K Buy
+200
New +$742 ﹤0.01% 644

Other funds holding AUPH

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

1832 Asset Management's AUPH Position: Q3 2015 in Review

1832 Asset Management sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2015, closing a stake of 200 shares — an estimated $1K sold.

1832 Asset Management first reported a position in AUPH in Q2 2015 and held it in 1 quarter. The position peaked at $1K in Q2 2015. 12 funds tracked by Wall St. Rank hold AUPH as of Q3 2015.

  • 1832 Asset Management reported no remaining Aurinia Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • 1832 Asset Management sold 200 Aurinia Pharmaceuticals shares in Q3 2015, an estimated $1K.
  • 1832 Asset Management first reported a position in Aurinia Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • 1832 Asset Management's Aurinia Pharmaceuticals position peaked at $1K in Q2 2015.
  • 12 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2015.

Based on 1832 Asset Management's 13F filing for Q3 2015, filed 12 Nov 2015.